<DOC>
	<DOCNO>NCT01054937</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability 4SC-203 single dose administration healthy volunteer .</brief_summary>
	<brief_title>Single Dose Study With 4SC-203 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Healthy male subject age 18 45 year ( include ) , good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen Subjects must able communicate well investigator , understand comply requirement study , understand sign write informed consent Evidence current previous clinically significant disease , medical condition find medical examination ( include vital sign ECG ) , opinion investigator would compromise safety subject quality data Current recent history significant renal , hepatic , haematological , immunological , gastrointestinal , endocrine , pulmonary , cardiac , neurological , cerebral disease would interfere subject 's participation trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>4SC-203</keyword>
	<keyword>Phase I</keyword>
	<keyword>single dose</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>